Portal de investigación
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with all treated in CR1 with allo-HCT from matched unrelated donors. A study from ALWP of the EBMT
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Giebel, S.
- Labopin, M.
- Salmenniemi, U.
- Socie, G.
- Bondarenko, S.
- Blaise, D.
- Kroeger, N.
- Vydra, J.
- Grassi, A.
- Bonifazi, F.
- Czerw, T.
- Anagnostopoulos, A.
- Lioure, B.
- Ruggeri, A.
- Ciceri, F.
- Savani, B.
- Spyridonidis, A.
- Peic, Z.
- Nagler, A.
- Mohty, M.
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Giebel,S,Labopin,M,Salmenniemi,U,Socie,G,Bondarenko,S,Blaise,D,Kroeger,N et al. Post-transplant cyclophosphamide versus antithymocyte globulin in patients with all treated in CR1 with allo-HCT from matched unrelated donors. A study from ALWP of the EBMT. 48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT). 2022. CZECH REPUBLIC-MAR 19-23. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND:SPRINGERNATURE. 2022 p.p. 13-14.